While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...

Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way. That’s a real nice CRISPR cure you have there. It would be a pity if ...

Kimberly Dawn Neumann is a New York City-based magazine and book writer whose work has appeared in a wide variety of publications, including Women’s Health, Health, Cosmopolitan, Fitness, Prevention, ...

Biohacking not only offers strategies to improve ourselves as individuals, but also presents investment opportunities for future-oriented tech funders who want to play a part in humanity’s growth as a ...

CRISPR Therapeutics now has an approved product in its portfolio in Casgevy. The treatment has the potential to be a game changer for the company's business. Even with more treatments in its portfolio ...

The baby's disease prevented the liver from removing ammonia Half of babies with the disease die in their first week of life The baby has already shown signs of improvement The baby's disease ...

Crispr Therapeutics, a leader in CRISPR/Cas9 biotechnology, recently received FDA and EMA approval for Casgevy, the first CRISPR/Cas9-based treatment for TDT and SCD. The partnership with Vertex ...

io9 is proud to present fiction from LIGHTSPEED MAGAZINE. Once a month, we feature a story from LIGHTSPEED’s current issue. This month’s selection is “The CRISPR Cookbook (Chapter Two): A Guide to ...